MG-K10 Humanized Monoclonal Antibody Injection

BIOLOGICAL3 trials

Sponsors

Shanghai Mabgeek Biotech.Co.Ltd

Conditions

Atopic DermatitisAtopic EczemaChronic Spontaneous Urticaria (CSU)Seasonal Allergic Rhinitis

Phase 2

Phase II/III Seamless Clinical Study of MG-K10 Humanized Monoclonal Antibody Injection in Treatment of Seasonal Allergic Rhinitis

RecruitingNCT06846385

Shanghai Mabgeek Biotech.Co.LtdSeasonal Allergic Rhinitis

Start: 2025-03-20End: 2025-09-30Target: 160Updated: 2025-04-18

Phase 3

A Study to Evaluate the Efficacy and Safety of MG-K10 in Participants Who Have Atopic Dermatitis

Not yet recruitingNCT07479615

Shanghai Mabgeek Biotech.Co.LtdAtopic Dermatitis, Atopic Eczema

Start: 2026-05-01End: 2029-01-01Target: 498Updated: 2026-03-18

A Study of MG-K10 in Chronic Spontaneous Urticaria

Not yet recruitingNCT07546487

Shanghai Mabgeek Biotech.Co.LtdChronic Spontaneous Urticaria (CSU)

Start: 2026-04-14End: 2028-03-31Target: 226Updated: 2026-04-22